CONVERGENE
ConverGene is a small molecule discovery company leveraging rational drug design. Our mission is to develop therapeutics with novel mechanisms of action for cancer patients with limited or no treatment options. ConverGene was founded in 2011 after a think tank comprised of six leaders in the fields of genomics and personalized medicine came to the realization that BET proteins could be the key to epigenetic control of MYC. The group decided to focus their deep medicinal chemistry expertise on th... e discovery of novel small molecules that would represent an alternative to the common benzodiazepine core molecules. We have evaluated thousands of molecules and have chosen a few of the most promising as clinical candidates based on improved cancer efficacy and lower side effects in our pre-clinical animal models. All of our initial leaders from 2011 are believers in our core technology and approach. They remain an integral part of ConverGene as Founders, members of our Management Leadership or members of the Scientific Advisory Board.
CONVERGENE
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.convergenepharma.com
Total Employee:
1+
Status:
Active
Total Funding:
850 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Wordpress Plugins Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Curadev Pharma Pvt. Ltd.
Curadev Pharma Pvt. Ltd. is a small molecule drug discovery biotech with an exciting portfolio of research programs
Current Employees Featured
Founder
Official Site Inspections
http://www.convergenepharma.com
- Host name: 71.88.62.50.host.secureserver.net
- IP address: 50.62.88.71
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ConverGene"
About - ConverGene
ConverGene is a small molecule discovery company leveraging rational drug design. Our mission is to develop therapeutics with novel mechanisms of action for cancer patients with limited or …See details»
Home - ConverGene
Developing First-in-Class Dual Inhibitors Targeting Both BET Bromodomains and Dopamine Receptor 2 for the Treatment of CancerSee details»
ConverGene Company Profile | Management and Employees List
Convergenepharma.com. Revenue. $1.1 M. Employees. 6. Primary Industries. Business Services Research & Development. ConverGene Executive Team & Key Decision Makers. Name & …See details»
ConverGene - Crunchbase Company Profile & Funding
ConverGene is a small molecule discovery company leveraging rational drug design. Our mission is to develop therapeutics with novel mechanisms of action for cancer patients with limited or no treatment options.See details»
ConverGene - Products, Competitors, Financials, Employees, …
Headquarters Location. 22 Firstfield Road Suite 280. Gaithersburg, Maryland, 20878, United States. 301-861-0009See details»
Convergene LLC Company Profile | Cambridge, MD - Dun
Find company research, competitor information, contact details & financial data for Convergene LLC of Cambridge, MD. Get the latest business insights from Dun & Bradstreet.See details»
Convergene LLC:Company Profile & Technical …
Convergene LLC is a company that provides Pharmacy and Therapeutics, Small molecule, Biomedicine and more. Convergene LLC is headquartered in United States Massachusetts.See details»
Convergene LLC: Drug pipelines, Patents, Clinical trials - Synapse
Jul 31, 2023 Explore Convergene LLC with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Neoplasms, Hemic and Lymphatic ...See details»
ConverGene - Overview, News & Similar companies | ZoomInfo.com
Popular Searches Convergene LLC Convergene convergence LLC Convergenepharma.com SIC Code 87,873 NAICS Code 54,541 Show more. Similar Companies to ConverGene. ENB …See details»
Convergene Llc - Company Info, Employees & Competitors
View Convergene llc convergenepharma.com location in Usa, revenue, industry and description. Find related and similar companies as well as employees by title and much more. Platform. …See details»
ConverGene 2025 Company Profile: Valuation, Funding
ConverGene General Information Description. Developer of cancer drugs designed to target the root regulatory mechanisms within cancer cells. The company engages in the discovery and …See details»
Convergene Announces Sponsored Research Agreement With MD …
Sep 18, 2017 ConverGene (www.convergenepharma.com) is a small molecule discovery company leveraging rational drug design. Our mission is to develop therapeutics with novel …See details»
News - ConverGene
Jan 11, 2017 ConverGene invited speaker at Drug Discovery Chemistry. April 24-25, 2017 in San Diego. ConverGene will present at Biotech Showcase during JP Morgan Healthcare …See details»
Convergence Pharma - 2025 Company Profile - Tracxn
Mar 28, 2025 Convergence Pharma has raised a total funding of $35.4M over 1 round. Its latest funding round was a Series A round on Oct 04, 2010 for $35.4M. 3 investors participated in its …See details»
Convergene LLC - Drug pipelines, Patents, Clinical trials - Synapse
Mar 9, 2025 Explore Convergene LLC with its drug pipeline, therapeutic area, technology platform, 5 literature, Disease Domain:Hemic and Lymphatic Diseases, Neoplasms, Nervous …See details»
H.I.G. Capital Completes Acquisition of Converge Technology …
2 days ago Headquartered in Tallahassee, Florida, the new organization will be led by a dynamic and experienced leadership team with over a century of combined experience in the IT …See details»
ConverGene - Company profile | ensun
Our mission is to develop therapeutics with novel mechanisms of action for cancer patients with limited or no treatment options. ConverGene is a small molecule discovery company …See details»
H.I.G. Capital Completes Acquisition of Converge Technology …
1 day ago H.I.G. is a leading global alternative investment firm with $69 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Los Angeles, …See details»
ConverGene Announces CRADA Agreement with The National …
CAMBRIDGE, Md., April 05, 2017 (GLOBE NEWSWIRE) — ConverGene has entered into a Collaborative Research and Development Agreement (CRADA) with the Molecular …See details»
H.I.G. Capital Completes Merger of Converge Technology …
2 days ago H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $69 billion of capital under management, is pleased to announce that one of its affiliates has completed …See details»